Lv2
110 积分 2023-03-16 加入
Ruxolitinib cream in adults with moderate atopic dermatitis after failure of other topicals: A randomized trial
1个月前
已完结
Safety, tolerability, and pharmacokinetics of HL-300, a novel topical pan-JAK inhibitor, in healthy Chinese adults: a first-in-human, randomized, double-blind, placebo-controlled phase I trial
2个月前
已完结
Randomized dose-finding study of anti-KIT barzolvolimab in patients with chronic spontaneous urticaria
2个月前
已完结
Osteoarthritis: Joint Anatomy, Physiology, and Pathobiology
3个月前
已完结
Organ-specific tumor dynamics predict survival of patients with metastatic colorectal cancer
3个月前
已完结
Long‐term efficacy of abrocitinib in patients with moderate‐to‐severe atopic dermatitis to 2 years
3个月前
已完结
Peficitinib halts acute kidney injury via JAK/STAT3 and growth factors immunomodulation
5个月前
已完结
Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial
5个月前
已完结
Clinical characteristics and causes of pruritus in cats: a multicentre study on feline hypersensitivity‐associated dermatoses
5个月前
已完结
皖公网安备34019202002308
